Company news

Immutep Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PRR Collaborates In New Clinical Trial For Imp321

July 12, 2016

First Data From Phase IIb Clinical Trial of Imp321

June 21, 2016

Prima BioMed Files U.S Shelf Registration Statement

May 29, 2016

PRR Enters Agreement with Sydys to Advance CVac Program

May 12, 2016

Japanese Patent Grants For IMP321 In Cancer

May 1, 2016

Appendix 4C - quarterly March 2016

April 8, 2016

Proposed Acquisition of Immutep

March 30, 2016

First patient dosed in AIPAC

March 2, 2016

US patent granted for IMP731 antibody

February 11, 2016

Prima initiates Phase I melanoma study in Australia

February 10, 2016

← Newer news releases

Decks

The 5 newest of 95 decks. Every deck is listed under its year.